Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05951192 · ClinicalTrials.gov registry record · Phase 4
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
A Phase 4 study of Anemia and Renal Insufficiency, Chronic, sponsored by USRC Kidney Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 161
- Enrollment target
- 1
- Study location
NCT05951192: Completed Phase 4 study of Anemia and Renal Insufficiency, Chronic, sponsored by USRC Kidney Research.
NCT05951192 is a Phase 4 study of Anemia and Renal Insufficiency, Chronic that has completed, run by USRC Kidney Research. The registered enrollment target is 161 participants, below the 425-participant average among 72 other Anemia trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05951192, a Phase 4 study of Anemia and Renal Insufficiency, Chronic, has completed, sponsored by USRC Kidney Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 161 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigator-initiated, interventional, prospective study to assess the clinical and operational effectiveness of daprodustat in adult patients receiving in center hemodialysis or peritoneal home dialysis who are transitioning from Mircera to daprodustat.
Primary Outcome
Change in hemoglobin from baseline (defined as the mean of all available hemoglobin values obtained in the 30 days prior to Day 1) to the effectiveness evaluation period (mean of all available hemoglobin values obtained in the 30 days prior to Day 120).
Conditions Studied
Interventions
- DRUG Daprodustat
Study Locations (1)
Colorado
- USRC Kidney Research - Lone Tree
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2024-02-14 |
| Phase | Phase 4 |
What the finished NCT05951192 record still lists
NCT05951192 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 425-participant average among 72 other Anemia trials with a reported enrollment target (62% lower).
The record links to 3 conditions, with Anemia appearing as the primary indexed condition, and to 1 intervention - of which Daprodustat is the first listed.
NCT05951192 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05951192 about?
NCT05951192 is a clinical study titled "A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease". Investigator-initiated, interventional, prospective study to assess the clinical and operational effectiveness of daprodustat in adult patients receiving in center hemodialysis or peritoneal home dialysis who are transitioning from Mircera to daprodustat.
What is the current status of trial NCT05951192?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 161 participants. The study started on 2023-07-01. Estimated completion is 2024-02-14.
What conditions does trial NCT05951192 study?
This clinical trial studies the following conditions: Anemia, Renal Insufficiency, Chronic, Renal Anemia.
What interventions are being tested in trial NCT05951192?
The interventions under investigation include: Daprodustat (DRUG).
Who is sponsoring clinical trial NCT05951192?
This trial is sponsored by USRC Kidney Research, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05951192 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05951192's enrollment target sits among peer trials
161 37th of 72 higher than 36 of 72 other Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Iron Deficiency Anemia (IDA) and the Brain
RECRUITING · Phase 4
-
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
COMPLETED · Phase 4
-
Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients
COMPLETED · Phase 4
-
IV Iron Safety: Evaluation of Iron Species in Healthy Subjects
COMPLETED · Phase 4
-
Prevention of Iron Deficiency in Breastfed Infants
COMPLETED · Phase 4
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI